BiotechTube

Dupilumab

ApprovedRecruiting
0 views this week 0 watching⚡ Active
Interest: 50/100
50
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Chronic Rhinosinusitis With Nasal Polyps

Conditions

Chronic Rhinosinusitis With Nasal Polyps, Asthma

Trial Timeline

Aug 1, 2024 → Dec 1, 2025

NCT ID
NCT06556264

About Dupilumab

Dupilumab is a approved stage product being developed by Sanofi for Chronic Rhinosinusitis With Nasal Polyps. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06556264. Target conditions include Chronic Rhinosinusitis With Nasal Polyps, Asthma.

What happened to similar drugs?

20 of 20 similar drugs in Chronic Rhinosinusitis With Nasal Polyps were approved

Approved (20) Terminated (3) Active (0)
✅Pegasys® + Pegasys®Chugai PharmaceuticalApproved
✅Telmisartan/Rosuvastatin 40/10mg + Telmisartan 40mgYuhanApproved
✅placebo + aspirin + clopidogrel + aspirin OR prasugrel + aspirinDaiichi SankyoApproved
✅alefacept + polyvalent pneumococcal vaccineAstellas PharmaApproved
✅alefaceptAstellas PharmaApproved
✅AlefaceptAstellas PharmaApproved
✅lysozyme 90 mg + PlaceboEisaiApproved

Hype Score Breakdown

Clinical
20
Activity
15
Company
15
Novelty
0
Community
0

Clinical Trials (20)

NCT IDPhaseStatus
NCT05906706Pre-clinicalCompleted
NCT07316114Pre-clinicalRecruiting
NCT07467564Pre-clinicalRecruiting
NCT07187089ApprovedWithdrawn
NCT07112378Phase 3Recruiting
NCT07052396Pre-clinicalRecruiting
NCT07276425Pre-clinicalRecruiting
NCT06695897Pre-clinicalRecruiting
NCT06693531Pre-clinicalRecruiting
NCT06415175Pre-clinicalActive
NCT06556264ApprovedRecruiting
NCT06352073ApprovedRecruiting
NCT06293053Phase 3Recruiting
NCT05983068ApprovedActive
NCT06234761Pre-clinicalRecruiting
NCT05991323Pre-clinicalActive
NCT06192563Pre-clinicalRecruiting
NCT06169527Pre-clinicalActive
NCT06393946Pre-clinicalActive
NCT05831176Phase 2Active

Competing Products

20 competing products in Chronic Rhinosinusitis With Nasal Polyps

See all competitors
ProductCompanyStageHype Score
Levofloxacin 500Dr. Reddy's LaboratoriesPre-clinical
23
mRNA-0184ModernaPhase 1
0
Lubiprostone + Lubiprostone + PlaceboDr. Reddy's LaboratoriesPhase 3
37
macitentan 10 mgBML, Inc.Phase 3
32
KPL-716 + PlaceboKiniksa PharmaceuticalsPhase 2
29
TERN-701Terns PharmaceuticalsPhase 1/2
36
Fludarabine + Cyclophosphamide + PRGN-3007PrecigenPhase 1
23
LY3556050 + PlaceboEli LillyPhase 2
35
THB001Third Harmonic BioPhase 1
11
BriquilimabJasper TherapeuticsPhase 1/2
26
BriquilimabJasper TherapeuticsPhase 1/2
14
BriquilimabJasper TherapeuticsPhase 2
29
Empagliflozin + Matching placeboEli LillyPhase 3
40
LY3461767 + PlaceboEli LillyPhase 1
29
Pirtobrutinib + Venetoclax + RituximabEli LillyPhase 3
44
LY3526318 + PlaceboEli LillyPhase 2
35
PirtobrutinibEli LillyPhase 2
42
Ibrutinib + LY3214996Eli LillyPhase 1
21
Pirtobrutinib + AcalabrutinibEli LillyPhase 2
27
LYR-210Lyra TherapeuticsPhase 2
25